R
Rapt Therapeutics (RAPT)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Rapt Therapeutics (RAPT)
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It... Read more
- USD7.72
- USD8.53
- USD7.71
- USD27.35
- -14.30%
- --
- 1.09M
- 817.29k
- 282M
- 6.86
- -57.70%
Stock News
3 hours ago
Herbalife Reports Year-Over-Year Net Sales Growth for Second Consecutive Quarter; Raises Full-Year 2024 Adjusted EBITDA1 Guidance
Yahoo
3 hours ago
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
Yahoo
3 hours ago
Sunoco LP and NuStar Energy L.P. Announce NuStar's Unitholder Approval of the Sunoco Transaction
Yahoo
3 hours ago
Embarking on History: Concord Pacific Racing Propels Team Canada's Pursuit of the Inaugural Puig Women's America's Cup
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
